semaglutide 7.2 mg clinical trial The FDA has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing Cardiovascular Outcomes, Safety, and Tolerability

Himsworth observed that older patients were more likely to have type 2 diabetes and that decreasing a patient's weight through diet helped to reduce diabetic symptoms and restore their sugar tolerance back to normal (Kim)

Your program is designed around your labs, your body composition, and your medical history

Seek medical attention if you experience severe or worsening weakness that interferes with daily activities, signs of dehydration (decreased urination, dizziness, confusion), symptoms of low blood sugar, persistent vomiting preventing adequate oral intake, or severe abdominal pain that could indicate pancreatitis

The best way to avoid this is to track your food, including macros, to ensure you get enough protein